Chiron Real Estate (XRN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
10 Aug, 2026Executive summary
Leadership team expanded with experienced hires, including new CIO, COO, and Head of Seniors Housing, to support a strategic pivot toward seniors housing and portfolio repositioning.
Significant progress made on capital allocation, asset sales, and acquisitions, including the $249 million purchase of two luxury seniors housing communities and the sale of seven inpatient rehab facilities for $217 million, retaining a 15% JV interest.
Transition underway from outpatient medical assets to higher-returning healthcare real estate, especially seniors housing, with SHOP now representing 25% of the portfolio.
Originated mezzanine loans totaling $5.2 million for under-development medical facilities, both 100% pre-leased to investment-grade tenants.
Portfolio repositioning aligns with industry trends toward healthcare-focused real estate and operational excellence.
Financial highlights
Net income for Q2 2026 was $72.3 million, up from $0.6 million in the prior year, driven by a $71.9 million gain on property sales.
Core FFO for the quarter was $15.1 million ($1.04 per share and unit), down from $16.6 million ($1.14 per share and unit) in the prior year.
Annualized Cash NOI for Q2 2026 was $106.5 million; same-store cash NOI increased 0.8% year-over-year, or 1.7% excluding a one-time item.
Cash and cash equivalents and restricted cash increased to $12.9 million as of June 30, 2026.
GAAP-redefined FFO per share and unit was $0.88 for the quarter.
Outlook and guidance
SHOP segment expected to become a more significant contributor as newly acquired communities stabilize and additional acquisitions close.
Dividend reduced from $0.25 to $0.16 per share monthly to retain cash and accelerate the acquisition strategy.
Focus remains on acquiring stabilized seniors housing assets and recycling capital from outpatient medical sales, with a large pipeline of investment opportunities identified.
The Landing and Riviera communities are expected to deliver yields above 7% upon stabilization in 2H 2028.
Management expects to unlock embedded value through active capital recycling and disciplined investment criteria.
Latest events from Chiron Real Estate
- Portfolio shift to higher-return senior housing assets and JV unlocks $200M for reinvestment.XRN
Corporate presentation - Healthcare REIT registers Series C Preferred and Common Stock for resale by major investors.XRN
Registration filing - $425M in senior housing acquisitions, $100M equity, and 36% dividend cut drive growth.XRN
Q1 2026 - Q3 2025 net loss from impairment, but FFO/AFFO and rental revenue grew year-over-year.XRN
Q3 2025 - AFFO and FFO rose, occupancy remained high, and dividend was cut to support growth and stability.XRN
Q2 2025 - Q3 2024 featured resilient occupancy, lower net income, and active acquisitions amid market challenges.XRN
Q3 2024 - Q2 net loss from property sale, but AFFO, occupancy, and acquisition activity remain strong.XRN
Q2 2024 - AFFO guidance reaffirmed as net income rises and portfolio expands despite tenant bankruptcy.XRN
Q1 2025 - Strong Q4 results and stable AFFO, with acquisitions and JV supporting 2025 growth.XRN
Q4 2024